AptarGroup, Inc.

NYSE:ATR

Medical - Instruments & Supplies

Healthcare
$141.67 +0.55%

+$0.66 today

Market cap
$8.98B
Beta
0.40
P/E (TTM)
20.0
EPS (TTM)
$6.04
Dividend yield
1.57%
52W Low $103.23High $164.28

Volume 0.34M

Average 0.51M

ATR Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

AptarGroup, Inc.NYSE: ATR

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin narrows to 8.5%

Net margin was 8.5% in Q2 FY2026, down 3.0 pp from a year earlier. On a trailing-twelve-month basis it was 9.2%, down 1.6 pp year over year. Over 3 fiscal years it widened by 3.2 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 7 analysts of 9.2% for the fiscal year ending Dec 2026, down from 10.4% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
8.5%+1.1 pp QoQ
Last fiscal yearDec 2025
10.4%-0.1 pp YoY
LTMJun 2026
9.2%-1.6 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.0 pp-3.7 pp-0.7 pp
1 year-0.1 pp-1.2 pp-1.1 pp
3 years+3.2 pp-0.7 pp-3.9 pp
5 years+1.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
10.4%
Year-over-year change
-0.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How ATR compares with its peers on the latest reported figures

  • ATR's LTM Jun 2026 net margin of 9.2% is the 4th highest of the 7 companies compared; the peer median is 7.8%.
  • Its year-over-year change of -1.6 pp is the 6th highest of 7, against a peer median of -0.1 pp.
  • Over three fiscal years its change of +3.2 pp compares with a peer median of -2.6 pp.
ATR Competitors Peer median
Net Margin for ATR and competitors
Company Period LTM level YoY 3-year change
TRSTriMas CorporationLTM Mar 2026104.7% +100.6 pp+11.1 pp
WSTWest Pharmaceutical Services, Inc.LTM Jun 202617.0% +0.5 pp-4.2 pp
STVNStevanato Group S.p.A.LTM Jun 202611.0% -0.8 pp-2.7 pp
ATRAptarGroup, Inc.LTM Jun 20269.2% -1.6 pp+3.2 pp
AMCRAmcor plcLTM Jun 20264.7% +1.3 pp-2.4 pp
SLGNSilgan Holdings Inc.LTM Jun 20264.0% -0.9 pp-0.9 pp
SONSonoco Products CompanyLTM Sep 2026-2.8% -13.1 pp-2.7 pp
Peer median (excluding ATR) 7.8%-0.1 pp-2.6 pp

Competitors are the stored peer set for ATR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.23B3.32B3.49B3.58B3.78B
Cost of Revenue2.07B2.16B2.22B2.23B2.66B
Gross Profit1.16B1.16B1.26B1.36B1.12B
Gross Margin35.8%35.0%36.2%37.8%29.6%
Research & Development99.8M000105.1M
Selling, General & Admin551.24M544.26M565.78M582.23M499.94M
Operating Expenses809.34M784.57M859.38M859.01M605.04M
Depreciation & Amortization234.85M233.71M248.59M263.78M287.36M
EBITDA586.79M609.41M663.84M777.45M831.48M
EBITDA Margin18.2%18.3%19.0%21.7%22.0%
Operating Income347.35M379.27M404.02M496.5M512.34M
Operating Margin10.8%11.4%11.6%13.9%13.6%
Interest Income3.67M2.7M4.37M12.1M11.68M
Interest Expense30.28M40.83M40.42M43.9M52.74M
Other Income / Expenses(25.69M)(44.57M)(29.19M)(26.73M)(20.96M)
Income Before Tax321.66M334.7M374.83M469.77M491.38M
Pre-Tax Margin10.0%10.1%10.7%13.1%13.0%
Income Tax Expense78.02M95.15M90.65M95.59M98.88M
Net Income244.1M239.29M284.49M374.54M392.79M
Net Margin7.6%7.2%8.2%10.5%10.4%
EPS (Basic)3.723.664.345.655.97
EPS (Diluted)3.603.594.255.535.88
Weighted Avg Shares65.66M65.4M65.62M66.33M65.74M
Weighted Avg Shares (Diluted)67.68M66.72M66.91M67.69M66.72M

AptarGroup, Inc.

NYSE:ATR

Intrinsic Alpha fair value

Locked

Current Price

$141.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.